Results 11 to 20 of about 109,382 (263)

Mutation Profile of Well-Differentiated Thyroid Cancer in Asians [PDF]

open access: yesEndocrinology and Metabolism, 2015
Recent advances in molecular diagnostics have led to significant insights into the genetic basis of thyroid tumorigenesis. Among the mutations commonly seen in thyroid cancers, the vast majority are associated with the mitogen-activated protein kinase ...
Young Shin Song   +2 more
doaj   +1 more source

One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma

open access: yesJournal of Bone Oncology, 2021
EWS/FLI is the defining mutation of Ewing sarcoma. This oncogene drives malignant transformation and progression and occurs in a genetic background characterized by few other recurrent cooperating mutations. In addition, the tumor is absolutely dependent
Guillermo Flores, Patrick J. Grohar
doaj   +1 more source

Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein [PDF]

open access: yesOncogene, 2003
In Ewing's sarcoma family tumors, the ets transcription factor gene FLI1 is rearranged with one EWS allele resulting in coexpression of germline EWS and chimeric EWS-FLI1 proteins. Here, we investigated the potential of germline EWS, FLI1 and EWS-FLI1 to oligomerize. In two functional in vivo tests, fluorescence resonance energy transfer (FRET) and the
Laura, Spahn   +5 more
openaire   +2 more sources

Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer. [PDF]

open access: yesPLoS ONE, 2015
TMPRSS2-ERG junction oncogene is present in more than 50% of patients with prostate cancer and its expression is frequently associated with poor prognosis.
Giorgia Urbinati   +6 more
doaj   +1 more source

Epigenome Mapping Reveals Distinct Modes of Gene Regulation and Widespread Enhancer Reprogramming by the Oncogenic Fusion Protein EWS-FLI1

open access: yesCell Reports, 2015
Transcription factor fusion proteins can transform cells by inducing global changes of the transcriptome, often creating a state of oncogene addiction.
Eleni M. Tomazou   +8 more
doaj   +1 more source

Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion

open access: yesBMC Cancer, 2019
Background Genetic alterations, including mutation of epidermal growth factor receptor or v-Ki-ras2 kirsten rat sarcoma viral oncogene homolog and fusion of anaplastic lymphoma kinase (ALK), RET proto-oncogene (RET), or v-ros UR2 sarcoma virus oncogene ...
Koh Furugaki   +5 more
doaj   +1 more source

MTAP-ANRIL gene fusion promotes melanoma epithelial-mesenchymal transition-like process by activating the JNK and p38 signaling pathways

open access: yesScientific Reports, 2023
Gene fusions caused by cytogenetic aberrations play important roles in the initiation and progression of cancers. The recurrent MTAP-ANRIL fusion gene was reported to have a frequency of greater than 7% in melanoma in our previous study.
Zhuoying Lin   +5 more
doaj   +1 more source

Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing [PDF]

open access: yesProceedings of the National Academy of Sciences, 2007
MicroRNAs (miRNAs) are noncoding small RNA of ≈22 bases, which suppress expression of target genes through translational block or degradation of a target's transcript. Recent studies uncovered specific miRNA expression profiles in human malignancies.
Tatsuya Nakamura   +2 more
openaire   +3 more sources

Oncogenic fusion protein FGFR2-PPHLN1: Requirements for biological activation, and efficacy of inhibitors [PDF]

open access: yesTranslational Oncology, 2020
Chromosomal translocations such as t(10;12)(q26,q12) are associated with intrahepatic cholangiocarcinoma, a universally fatal category of liver cancer. This translocation creates the oncogenic fusion protein of Fibroblast Growth Factor Receptor 2 joined to Periphilin 1.
Li, Fangda   +4 more
openaire   +4 more sources

Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2015
Myeloproliferative neoplasms are caused by a clonal proliferation of a hematopoietic progenitor. First described in 1951 as 'Myeloproliferative Diseases' and reevaluated by the World Health Organization classification system in 2011, myeloproliferative ...
Renata Mendes de Freitas   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy